Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 29, 2019	Sep. 23, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 465,789	$ 533,360
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	64,664	79,805
Deferred income taxes	(2,992)	(83,501)
Equity-based compensation expense	42,905	50,343
Amortization of note discounts and issuance costs	1,675	1,245
Other, net	4,026	2,191
Changes in operating assets and liabilities	(112,020)	136,843
Net cash provided by operating activities	464,047	720,286
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(39,256)	(56,098)
Purchases of available-for-sale securities	(147,632)	(749,829)
Maturities of available-for-sales securities	600,347	70,216
Sales of available-for-sale securities	337,763	67,030
Other, net	(540)	(3,650)
Net cash provided by (used for) investing activities	750,682	(672,331)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(28,965)	(79,831)
Net repayments of commercial paper	0	(86)
Treasury stock purchases	(78,132)	(1,735,895)
Dividends paid	(158,868)	(174,372)
Proceeds from issuance of common stock	3,869	0
Other, net	0	(9)
Net cash used for financing activities	(262,096)	(1,990,193)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(4,193)	(2,311)
Net increase (decrease) in cash, cash equivalents, and restricted cash	948,440	(1,944,549)
Cash, cash equivalents, and restricted cash at beginning of period	3,913,396	4,768,558
Cash, cash equivalents, and restricted cash at end of period	4,861,836	2,824,009
Schedule of non-cash transactions:
Accrued payables for stock repurchases	13	162
Accrued payables for capital expenditures	30,333	36,613
Transfers of inventory to property and equipment, net	13,997	25,613
Reconciliation of cash, cash equivalents, and restricted cash
Total cash, cash equivalents, and restricted cash	$ 3,913,396	$ 4,768,558